ZIMVIE INC

ZimVie Inc. manufactures and markets medical devices, including dental implants and spinal surgery hardware, that incorporate materials derived from animals. Its product portfolio includes bone graft substitutes made from porcine-derived carbonate apatite, a xenograft material sourced from pigs. The company's piOs® Bone Graft is explicitly identified in published clinical research as a slow-resorbing xenograft based on porcine carbonate apatite.

The company was spun off from Zimmer Biomet Holdings, Inc. in 2022. Zimmer Biomet's sustainability reports, which historically covered ZimVie's operations, state that the parent company's use of animal testing was consistent with animal welfare acts globally. As a standalone entity continuing the development and sale of medical devices utilizing animal-derived biomaterials, ZimVie's business model is predicated on the commercial exploitation of animals. The evidence gathered does not specify the scale of animal-derived material in its revenue or provide details on its specific animal testing protocols post-spinoff.